Does PEGFILGRASTIM Cause Application site haemorrhage? 1,394 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,394 reports of Application site haemorrhage have been filed in association with PEGFILGRASTIM (ZIEXTENZO). This represents 1.7% of all adverse event reports for PEGFILGRASTIM.
1,394
Reports of Application site haemorrhage with PEGFILGRASTIM
1.7%
of all PEGFILGRASTIM reports
0
Deaths
18
Hospitalizations
How Dangerous Is Application site haemorrhage From PEGFILGRASTIM?
Of the 1,394 reports, 18 (1.3%) required hospitalization.
Is Application site haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGFILGRASTIM. However, 1,394 reports have been filed with the FAERS database.
What Other Side Effects Does PEGFILGRASTIM Cause?
Device adhesion issue (11,326)
Wrong technique in product usage process (10,217)
Unintentional medical device removal (8,882)
Device malfunction (6,818)
Device use error (6,001)
Device issue (5,071)
Accidental exposure to product (4,967)
Device occlusion (3,239)
Off label use (3,228)
Bone pain (2,266)
What Other Drugs Cause Application site haemorrhage?
MINOXIDIL (78)
BUPRENORPHINE (68)
ESTRADIOL (64)
DOCOSANOL (62)
BECAPLERMIN (60)
INGENOL MEBUTATE (50)
FENTANYL (47)
EVOLOCUMAB (45)
NICOTINE (37)
FLUOROURACIL (33)
Which PEGFILGRASTIM Alternatives Have Lower Application site haemorrhage Risk?
PEGFILGRASTIM vs PEGFILGRASTIM-APGF
PEGFILGRASTIM vs PEGFILGRASTIM-BMEZ
PEGFILGRASTIM vs PEGFILGRASTIM-CBQV
PEGFILGRASTIM vs PEGFILGRASTIM-JMDB
PEGFILGRASTIM vs PEGINTERFERON ALFA